scholarly journals THE COST OF NOT BREASTFEEDING IN NORTH SUMATERA

2019 ◽  
Author(s):  
Estro Dariatno Sihaloho ◽  
Rahma ◽  
Wandira Larasati Senja ◽  
Pipit Pitriyan ◽  
Adiatma Y.M Siregar

Breastfeeding provide many good impacts on health and economics side. This study tries toestimate the economic impact of not breastfeeding due to diarrhea and PRD cases in NorthSumatera. The economic impact elaborated by finds health system medical cost and thepatient/non- medical cost. This paper calculates health system medical cost from publichospital, private hospital, and primary health center while the patient cost calculated from135 patients in 3 kinds of health facilities. This paper combines primary data with CensusData 2010 and IDHS 2012 to get total cost of not breastfeeding in North Sumatera. Thecosting process shows there are economic loss about US$1,290,582 with average cost aboutUS$ 13.48 in North Sumatera. The total cost consist of health system perspective costabout US$ 799,050 and patient costs about 491,532. This show that most of the cost comesfrom the health system cost/medical cost about 61.91% and the 38.09% borne from thepatient costs and non-medical cost

2020 ◽  
Vol 7 (3) ◽  
Author(s):  
Estro Dariatno Sihaloho

Breastfeeding provide many good impacts on health and economics side. This study tries to estimate the economic impact of not breastfeeding due to diarrhea and PRD cases in North Sumatera. The economic impact elaborated by finds health system medical cost and the patient/non- medical cost. This paper calculates health system medical cost from public hospital, private hospital, and primary health center while the patient cost calculated from 135 patients in 3 kinds of health facilities. This paper combines primary data with Census Data 2010 and IDHS 2012 to get total cost of not breastfeeding in North Sumatera. The  costing process shows there are economic loss about US$1,290,582 with average cost about US$ 13.48 in North Sumatera. The total cost consist of health system perspective cost about US$ 799,050 and patient costs about 491,532. This show that most of the cost comes from the health system cost/medical cost about 61.91% and the 38.09% borne from the patient costs and non-medical cost


2021 ◽  
Author(s):  
Zuojun Dong ◽  
Zhichao Hu ◽  
Xiaoying Zhou ◽  
Jingwen Wang ◽  
Jianwei Wang ◽  
...  

Abstract Objective The aim of this study is to evaluate the cost-effectiveness of teriflunomide and fingolimod in relapsing-remitting patients in the first-line treatment from the perspective of the Chinese health system perspective.Methods A Markov model was developed to evaluate the cost effectiveness of disease-modifying drugs (DMDs) from the Chinese health system perspective.Cost input includes medication, follow-up, nursing, recurrence treatment and adverse reaction management.Treatment effects, including monthly confrmed disability worsening and annualized relapse rate.The output result was ICER and the threshold of willingness to pay(WTP) was three times per capita GDP.One-way sensitivity analysis and probability sensitivity analysis are carried out to test the stability of the model results.Results In the context of medical insurance with Chinese characteristics.The total cost of treatment with teriflunomide was ¥423,816.61, and the total cost of treatment with fingolimod was ¥656,055.95.The cumulative QALYs of teriflunomide was 5.14, and the cumulative QALYs of fingolimod was 5.25.The ICER value of Fingolimod and Liflunomide is ¥2139444.61/QALY, which is higher than WTP , so teriflunomide has a dominant advantage.Sensitivity analysis proves that the model was stable.Conclusion From the perspective of Chinese health system perspective, teriflunomide is the more cost-effective of the two interventions.


2020 ◽  
Vol 114 (9) ◽  
pp. 642-649 ◽  
Author(s):  
Samara Freire Valente Magalhães ◽  
Henry Maia Peixoto ◽  
Jacqueline de Almeida Gonçalves Sachett ◽  
Sâmella S Oliveira ◽  
Eliane Campos Alves ◽  
...  

Abstract Background Snakebites account for significant morbidity and mortality. Their occurrence in the Brazilian Amazon warrants an analysis that will enable better understanding of their economic impact and thus contribute to their management and prevention. This study aimed to estimate the cost of snakebite envenomation in the Brazilian Amazon in 2015. Methods We conducted a cost-of-illness study of snakebite in the Brazilian Amazon in 2015 based on official surveillance data to estimate burden from a societal, patient and public health system perspective. Direct medical costs were estimated via a top-down approach. Loss of productivity was estimated by a human capital approach. Results The study included 11 503 cases and 56 deaths. The estimated cost to the health system was US$3.115.861,28. The estimated cost due to premature death caused by snakebite was US$3031 300.38. The cost attributed to the loss of productivity due to absence from work was US$1539 518.62. The estimated cost from the patient's perspective was US$268 914.18. Therefore the total cost of snakebite in the Brazilian Amazon was estimated to be almost than US$8 million in 2015. Conclusions The economic burden of snakebite in Brazilian Amazon is notably high. Snakebites cause loss of productivity through inpatient treatment or deaths.


2019 ◽  
Vol 5 (3) ◽  
pp. 242
Author(s):  
Estro Dariatno Sihaloho ◽  
Rahma Rahma ◽  
Wandira Larasati Senja ◽  
Pipit Pitriyan ◽  
Adiatma Y.M Siregar

<p align="justify"><em>The knowledge of the importance of exclusive breastfeeding is still low in East Nusa Tenggara. Many families have started providing complementary foods like bananas or porridge, to their babies when they are only 2 months old. Providing complementary foods since babies 2 months old will increase the possibility of diarrhea and pneumonia/respiratory of babies. This study has three objectives. The first objective tries to estimate the economic impact of non-breastfeeding in East Nusa Tenggara. The second objective tries to calculate the health system medical cost and the third objective tries to calculate the patient/non-medical cost. This paper calculates the patient cost from 153 patient data collected from Kupang district in 2016. This paper estimates the economic impact by combining the health system cost, patient/non-medical cost with the prevalence data from IDHS 2012. This study finds that total economic losses caused by non-exclusive breastfeeding due to diarrhea and pneumonia/respiratory about US$ 2,718,497.  This study finds the average cost due to non-exclusive breastfeeding for diarrhea cases about US$ 9.3 and PRD cases about US$8.4.</em><em></em></p><p><br /><em></em></p>


Sign in / Sign up

Export Citation Format

Share Document